Cargando…
Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma?
Chronic obstructive pulmonary disease (COPD) patients are at increased risk of developing nonsmall cell lung carcinoma, irrespective of their smoking history. Although the mechanisms behind this observation are not clear, established drivers of carcinogenesis in COPD include oxidative stress and sus...
Autores principales: | Ng Kee Kwong, Francois, Nicholson, Andrew G., Harrison, Celeste L., Hansbro, Philip M., Adcock, Ian M., Chung, Kian Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488999/ https://www.ncbi.nlm.nih.gov/pubmed/29070578 http://dx.doi.org/10.1183/16000617.0040-2017 |
Ejemplares similares
-
PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD)
por: Ng Kee Kwong, F., et al.
Publicado: (2018) -
Mitochondrial Dysfunction as a Therapeutic Target in COPD
por: CHUNG, Kian Fan
Publicado: (2017) -
Cytokine inhibition in the treatment of COPD
por: Caramori, Gaetano, et al.
Publicado: (2014) -
Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD
por: Mumby, Sharon, et al.
Publicado: (2022) -
Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
por: Caramori, Gaetano, et al.
Publicado: (2014)